MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

19 Aug 2024 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC)’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..